NCT06061822 Artificial Intelligence Delivered Cardiac Magnetic Resonance - Prospective Validation
| NCT ID | NCT06061822 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Imperial College London |
| Condition | Cardiovascular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-05-01 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiac MRI (CMR) scanning allows doctors to create detailed images of the heart. However, the need for experienced cardiac radiographers to perform each scan can make CMR's delivery difficult, and some patients in the UK wait more than half a year for a scan. These radiographers must take pictures of different part of the heart, termed "views", each of which must be precisely positioned. The investigators believe they can revolutionise CMR, by using artificial intelligence to automatically position the views so radiographers can focus on more difficult tasks. The investigators have used a retrospective database of pseudonymised (anonymised and linked) CMR scans at our hospital to create these artificial intelligence (AI) algorithms, and they have validated them retrospectively on previous studies. The investigators now wish to test the algorithms prospectively. In this study, the investigators will recruit patients undergoing clinical CMR scans. In addition to the routine images acquired by expert radiographers, the investigators will require a duplicate set of images, positioned and planned by the AI algorithms. The investigators will then compare, within each patient, the AI-planned and expert-radiographer-planned scanning in terms of both speed and image quality.
Eligibility Criteria
Inclusion Criteria: * Adult (aged at least 18 years) Exclusion Criteria: * Children (patients below age 18). * Pregnant patients.
Contact & Investigator
James P Howard, MB BChir PhD
PRINCIPAL INVESTIGATOR
Imperial College London
Frequently Asked Questions
Who can join the NCT06061822 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06061822 currently recruiting?
Yes, NCT06061822 is actively recruiting participants. Contact the research team at james.howard1@imperial.ac.uk for enrollment information.
Where is the NCT06061822 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT06061822 clinical trial?
NCT06061822 is sponsored by Imperial College London. The principal investigator is James P Howard, MB BChir PhD at Imperial College London. The trial plans to enroll 150 participants.